A COVID-19 vaccine being considered by drug regulators could help quickly boost the number of Americans getting shots against the CCP (Chinese Communist Party) virus.
Johnson & Johnson …
A COVID-19 vaccine being considered by drug regulators could help quickly boost the number of Americans getting shots against the CCP (Chinese Communist Party) virus. Johnson & Johnson is prepared to tell members of Congress on Tuesday that it expects to have more than 20 million doses ready by the end of March to protect against COVID-19, the disease caused by the CCP virus. “Assuming necessary regulatory approvals relating to our manufacturing processes, our plan is to begin shipping immediately upon emergency use authorization, and deliver enough single-doses by the end of March to enable the vaccination of more than 20 million Americans,” Richard Nettles, vice president of U.S. medical affairs for a portion of Johnson & Johnson, will tell the House Energy and Commerce Committee, according to prepared remarks made public ahead of a Feb.23 committee hearing. “We are confident in our plans to deliver 100 million single-dose vaccines to the United States during the first half of 2021, and we are continuing to partner with the U.
